The Department of Science and Technology (DOST) said Thursday, Aug. 19, that the changes to clinical trial protocols have delayed the start of the country’s eight month-long study on the use of anti-parasitic drug Ivermectin as a treatment for coronavirus disease (COVID-19) in the country....